OncoBeta Africa

OncoBeta Africa is a specialized medical device and radiopharmaceutical company focused on providing innovative therapies for non-melanoma skin cancer (NMSC). As a regional subsidiary of the German-based OncoBeta GmbH, the company commercializes the Rhenium-SCT (Skin Cancer Therapy), a non-invasive, painless, and aesthetic epidermal radioisotope treatment. The therapy utilizes the beta-emitter Rhenium-188 to target and destroy cancer cells in basal cell and squamous cell carcinomas without the need for surgery. OncoBeta Africa works closely with clinics and dermatologists across the continent to expand access to this specialized brachytherapy. The company maintains strategic partnerships with local nuclear medicine providers to ensure the reliable supply and application of its radioisotope technology.